Drug and Gene Delivery Devices Market, By Product (Sub-retinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe, Pre-filled Syringe, and Infusion Bags), By Commercialized Drugs (Luxturna (Drug Delivery Devices), Yescarta (Drug Delivery Devices), Zolgensma (Drug Delivery Devices), Kymriah (Drug Delivery Devices), Provenge (Drug Delivery Devices), and Strimvelis (Drug Delivery Devices)), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Published In : Jun 2023

Code : CMI5864

Pages :155

Formats :

Excel and PDF

Industry : Pharmaceutical

Drug and Gene Delivery Devices MarketSize and Trends

The global drug and gene delivery devices market was valued at US$ 152.2 Thousand in 2022 and is forecast to reach a value of US$ 364.9 Thousand by 2030 at a CAGR of 11.6% between 2023 and 2030.

Based on geography, the global drug and gene delivery devices market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Europe and Asia Pacific are also expected to witness robust growth in the global drug and gene delivery devices market owing to the rise in burden of chronic diseases, such as infectious disease, cardiovascular disease, cancer, and diabetes, increasing demand for drug or gene delivery devices, and introduction of novel devices in these regions. For instance, according to the European Heart Network, each year, cardiovascular diseases (CVDs) cause more than 3.9 million deaths in Europe and around 1.8 million deaths in the European Union (EU). CVDs account for around 45% of all deaths in Europe and 37% of all deaths in the EU.

Figure 1. Global Drug and Gene Delivery Devices Market Share (%), by Region, 2023

Global Drug and Gene Delivery Devices Market Trends:

High demand for self-Administered drugs is a recent trend

Self-administered drugs are medicines a person can take at home, without assistance. The growing trend towards the self-administration of drugs has increased the demand for convenient and easy-to-use drug delivery systems. Moreover, with the development of novel drug delivery technologies and the continued focus on patient-centric healthcare, the demand for novel drug delivery devices is also increasing with a rapid pace, worldwide. This trend is expected to continue over the forecast period, driving the drug and gene delivery devices market growth.

Introduction of novel devices/therapies is another trend

With the increasing prevalence of chronic/targeted diseases across the globe, the demand for safe and effective drug and gene delivery devices as well as demand for novel cell and gene therapies is also increasing with a rapid pace. Thus, players in the market are focusing on developing and/or launching novel devices or therapies to meet growing demand. This trend is expected to continue over the forecast period, driving the growth of the market.